AEON
Price
$0.43
Change
-$0.03 (-6.52%)
Updated
Apr 25, 04:58 PM (EDT)
Capitalization
4.85M
GERN
Price
$1.42
Change
-$0.00 (-0.00%)
Updated
Apr 25, 04:59 PM (EDT)
Capitalization
904.42M
11 days until earnings call
Ad is loading...

AEON vs GERN

Header iconAEON vs GERN Comparison
Open Charts AEON vs GERNBanner chart's image
AEON Biopharma
Price$0.43
Change-$0.03 (-6.52%)
Volume$200
Capitalization4.85M
Geron
Price$1.42
Change-$0.00 (-0.00%)
Volume$113.45K
Capitalization904.42M
AEON vs GERN Comparison Chart
Loading...
GERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AEON vs. GERN commentary
Apr 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEON is a Hold and GERN is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 26, 2025
Stock price -- (AEON: $0.43 vs. GERN: $1.42)
Brand notoriety: AEON and GERN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AEON: 4% vs. GERN: 39%
Market capitalization -- AEON: $4.85M vs. GERN: $904.42M
AEON [@Biotechnology] is valued at $4.85M. GERN’s [@Biotechnology] market capitalization is $904.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $276.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AEON’s FA Score shows that 0 FA rating(s) are green whileGERN’s FA Score has 0 green FA rating(s).

  • AEON’s FA Score: 0 green, 5 red.
  • GERN’s FA Score: 0 green, 5 red.
According to our system of comparison, AEON is a better buy in the long-term than GERN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GERN’s TA Score shows that 5 TA indicator(s) are bullish.

  • GERN’s TA Score: 5 bullish, 3 bearish.

Price Growth

AEON (@Biotechnology) experienced а +6.27% price change this week, while GERN (@Biotechnology) price change was +11.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.17%. For the same industry, the average monthly price growth was -3.10%, and the average quarterly price growth was -10.42%.

Reported Earning Dates

AEON is expected to report earnings on Mar 24, 2025.

GERN is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+8.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GERN($904M) has a higher market cap than AEON($4.85M). GERN YTD gains are higher at: -59.887 vs. AEON (-98.893). AEON has higher annual earnings (EBITDA): -48.36M vs. GERN (-154.85M). GERN has more cash in the bank: 407M vs. AEON (16.2M). AEON has less debt than GERN: AEON (16.5M) vs GERN (122M). GERN has higher revenues than AEON: GERN (77M) vs AEON (0).
AEONGERNAEON / GERN
Capitalization4.85M904M1%
EBITDA-48.36M-154.85M31%
Gain YTD-98.893-59.887165%
P/E RatioN/AN/A-
Revenue077M-
Total Cash16.2M407M4%
Total Debt16.5M122M14%
FUNDAMENTALS RATINGS
GERN: Fundamental Ratings
GERN
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
90
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
69
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GERN
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
Bearish Trend 10 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
71%
Aroon
ODDS (%)
Bearish Trend 2 days ago
77%
View a ticker or compare two or three
Ad is loading...
GERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MLAAX8.880.13
+1.49%
NYLI Winslow Large Cap Growth Class A
GITIX32.28N/A
N/A
Goldman Sachs Technology Opps Inst
ALOIX31.69N/A
N/A
Virtus International S/C Instl
MWEMX45.00N/A
N/A
MFS Global Equity R6
SMUYX9.34N/A
N/A
SEI Multi-Strategy Alternative Y (SIMT)

AEON and

Correlation & Price change

A.I.dvisor indicates that over the last year, AEON has been loosely correlated with ONPPF. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if AEON jumps, then ONPPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AEON
1D Price
Change %
AEON100%
-6.43%
ONPPF - AEON
39%
Loosely correlated
N/A
GERN - AEON
28%
Poorly correlated
N/A
BLRX - AEON
24%
Poorly correlated
+7.26%
PSTV - AEON
22%
Poorly correlated
-6.50%
DAWN - AEON
22%
Poorly correlated
-2.03%
More

GERN and

Correlation & Price change

A.I.dvisor indicates that over the last year, GERN has been loosely correlated with SER. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if GERN jumps, then SER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GERN
1D Price
Change %
GERN100%
N/A
SER - GERN
66%
Loosely correlated
-3.94%
LIANY - GERN
53%
Loosely correlated
+8.63%
VCYT - GERN
44%
Loosely correlated
+0.28%
MIRM - GERN
39%
Loosely correlated
+0.82%
NRIX - GERN
37%
Loosely correlated
+0.35%
More